Cyclic peptides have attracted increasing attention in recent years due to their ability to inhibit proteinprotein interactions. Current strategies to prepare cyclic peptides often rely on functional amino acid side chains or the incorporation of unnatural amino acids, thus limiting their structural diversity. Here, we describe the development of a highly versatile peptide macrocyclization strategy through a palladiumcatalyzed C(sp 3 )-H activation and the synthesis of cyclic peptides featuring unique hydrocarbon linkages between the b-carbon of amino acids and the aromatic side chains of Phe and Trp. We demonstrate that such peptides exhibit improved biological properties compared to their acyclic counterparts. Finally, we applied this method in the synthesis of the natural product celogentin C.
Introduction
Peptides and peptidomimics are attracting increasing attention in both the chemical and pharmaceutical communities as a rich source of drug candidates and/or biological tools. 1 Since the clinical employment of gramicidin S, 2 hundreds of peptides have been identied from natural sources, and a number of them have advanced to the clinic. 3 One major driving force for the growing interest in these substances is their potency to interrupt or control biological events mediated by proteinprotein interactions (PPIs), which oen involve binding contacts spread over a surface. [4] [5] [6] [7] [8] [9] However, native peptides generally suffer from poor pharmacological properties and lack of structural diversity. 10 To address these limitations, various peptide modication strategies have been developed, among which macrocyclization is one of the most prominent methods. Compared to their acyclic counterparts, cyclic peptides generally have highly dened conformations, enhanced cell permeability, thermostability and resistance to proteolytic degradation.
11-13
Classic methods to generate cyclic peptides oen follow a one-component strategy, including head-to-tail lactamization, [14] [15] [16] internal disulde 17 or thioether formation, 18 ringclosing olen metathesis (RCM) [19] [20] [21] [22] and catalyzed cycloaddition of azides to alkynes 23 ( Fig. 1a) . A number of two-component cyclization procedures rely on external stapling agents, which usually utilize nucleophiles from lysine and cysteine residues. As a representative example, macrocyclization between lysine residues through nitrogen arylation by a peruoroaryl linker is reported by Pentelute and co-workers. 24, 25 Recently, several three-component macrocyclization methods were reported by Yudin and co-workers in the synthesis of aziridine-and oxadiazole-containing peptide macrocycles.
26,27
Despite the success achieved in this eld, limitations remain to be overcome. Peptides shorter than ve amino acids are generally difficult to cyclize by lactamization and oen lead to oligomerization.
14,15 For RCM and azide/alkyne cycloaddition, incorporation of a pair of unnatural amino acids at specic sites is usually required, making the preparation of precursor peptides challenging. 23, 28 The use of external stapling agents helps expand the structural diversity of cyclic peptides; however, Fig. 1 Peptide macrocyclization strategies and functionalization of the b-carbon of amino acids at the N-terminus of peptides via siteselective C(sp only amino acids with reactive side chains, such as lysine and cysteine (relative abundance z 1%), can be involved in these cyclization reactions. 29, 30 Such requirement excludes amino acids with chemically inert aliphatic side chains, which are highly abundant in naturally occurring peptides/proteins, as macrocyclization sites and thus signicantly limits the diversity of peptidomimics generated from these protocols. Therefore, strategies that could activate and involve these "inert" amino acids (e.g. at their b positions) in macrocyclization are highly desirable.
C-C coupling assisted by metal catalysis through direct C-H activation has now become a fundamental strategy to introduce functionalities to inert C-H bonds [31] [32] [33] [34] [35] and has found applications in the synthesis of cyclic peptide natural products. 36, 37 In our pursuit to generate peptidomimics with novel architecture for biological studies, we envisioned that peptide macrocyclization by activation of the b-carbon C-H bond of amino acids would help overcome the requirement for reactive amino acid side chains, since almost all amino acids contain a bcarbon (Gly as the only exception). Recently, Yu and co-workers reported their inspiring work in the Pd-catalyzed intermolecular arylation of a C(sp 3 )-H bond of N-terminal amino acid in oligopeptides without the installation of directing groups (Fig. 1b) . 38 We postulated that this method would allow peptide macrocyclization through intramolecular arylation with bcarbons of amino acids as stapling sites (Fig. 1c) .
In this work, we synthesized a variety of cyclic peptides containing unique Cb-Ar crosslinks between the b-carbon of amino acids (e.g., Ala, Val) and the aromatic ring of Phe/Trp through a Pd-catalyzed C(sp 3 )-H activation process. This method is highly versatile and compatible with the standard Fmoc SPPS procedure, resulting in cyclic peptides of different sizes. The impact of peptide conformation on the efficiency of macrocyclization is also investigated. Moreover, we demonstrated that peptidomimics generated from this method possess improved stability compared to their linear peptide precursors. In biological studies, cyclic RGD peptide generated by this method exhibited potent binding affinity to integrin. We also successfully applied this methodology to the synthesis of a peptide natural product containing b-carbon-to-Trp indole linkages.
Results and discussion

Investigation of Pd-catalyzed macrocyclization
To apply the Pd-catalyzed b-carbon arylation method to peptide macrocyclization, we started our initial attempt on a tetrapeptide 1a with the sequence of Phth-Ala-Gly-Gly-(m-I-Phe)-OMe (Phth ¼ phthaloyl, m-I-Phe ¼ meta-iodophenylalanine), where the N-and C-termini of the peptide were protected by phthaloyl and methyl group, respectively ( Fig. 2 , Scheme S1 †). This sequence was chosen because it contains minimal side chains and m-I-Phe provides direct access to peptides containing modied phenylalanine moieties. The installation of protecting groups was meant to minimize the undesired coordination to the Pd(II) catalyst. Aer optimization of reaction conditions (Table S1 †), it was found that with 1a (0.05 mmol), Pd(OAc) 2 (5 mol%) as the catalyst, AgOAc (1.2 equiv.) as the additive, in dichloroethane (DCE) at 100 C, the macrocyclization proceeded smoothly, and the desired product 2a was isolated in 62% yield. The resulting cyclic peptide 2a was characterized by analytical HPLC, high-resolution mass spectrometry (HRMS) and NMR analysis ( Fig. 2 and S1 †). Aer cyclization, the Ala bH peak shied signicantly ( Fig. 2a) in the 1 H NMR spectrum, and the newly formed macrocyclic linkage was further assigned by a diagnostic heteronuclear multiple bond correlation (HMBC) between the Ala bH and the Phe C3 (Fig. 2b) . No dimerization products were observed by either HPLC or MS analysis.
With optimized reaction conditions, we next evaluated the efficiency of this macrocyclization strategy on a variety of tetrapeptide sequences. The incorporation of aliphatic amino acids at position 2 (the second residue to the N-terminus), including Leu, Ile and b-branched Val (2b-2d), did not interrupt the cyclization process, and all afforded cyclic peptides in good isolated yields (53-58%, Table 1 ). In addition, the crosslinking occurred solely at the b-carbon of the N-terminal Ala, highlighting the regioselectivity of this methodology (see ESI † for structural characterization). Phe-containing peptide 1e and pentapeptide 1f cyclized efficiently under these conditions as well (Table 1) .
Next, we examined peptides with N-terminal residues other than Ala. Linear peptides 1g and 1h with N-terminal 2-aminioisobutyric acid (Aib) and Phe, respectively, were therefore synthesized and subjected to macrocyclization under standard conditions. Results showed that the C-H activation of bH (Aib) in peptide 1g was successful by yielding cyclic peptide 2g in 52% yield. The crosslink in 2g showed low diastereoselectivity (d.r. 60 : 40), as determined by 1 H NMR and LC-MS analysis (Fig. S2a †) . On the other hand, the activation of bH (Phe) in peptide 1h was much less efficient and resulted in a cyclization yield of only 19%, whereas a signicant amount of deiodination product was observed by LC-MS, indicating the challenge of crosslinking at the bC of a bulky Phe residue. In contrast to diastereoselectivity observed in peptide 2g, NMR and LC-MS analysis indicated that the resulting cyclic peptide 2h was a single diastereomer (Fig. S2b †) . The vicinal coupling between Ha and Hb of Phe1 of the cyclic peptide 2h was determined to be 12.0 Hz by 1 H NMR, suggesting an antiperiplanar arrangement of these two protons and therefore an R conguration of Phe1 Cb in peptide 2h.
To explore the feasibility of performing peptide macrocyclization in solid phase, we rst inserted Ser, Lys and Asp residues with side chains masked by standard Fmoc SPPS protecting groups (1i-1k). Results showed that these bulky protecting groups at position 2 were compatible with cyclization conditions without lowering the macrocyclization yields (Table  1) . Encouraged by these results, using 2-chlorotrityl chloride resin and following standard Fmoc SPPS procedure, we synthesized peptide 1l with the sequence resin-Gly-(m-I-Phe)-Gly-Gly-Ala-Phth (Table 1 and Scheme S2 †). On-resin macrocyclization was achieved with Pd catalyst in DMF at 100 C for 16 h. The resulting cyclic peptide was cleaved from the resin by TFA and puried by RP-HPLC. NMR and HRMS analysis conrmed that cyclic peptide 2l was successfully synthesized; however, the isolation yield was lower than solution-phase reactions ( Table 1 ). The synthesis of 2l was the rst example in which I-Phe is not positioned at the C-terminus of the oligopeptide during cyclization, demonstrating the potential of such method in building in-sequence rings. Interestingly, when para-and ortho-I-Phe was incorporated at the C-terminus of tetrapeptides, none were cyclized successfully, and only deiodination products were detected by MS analysis (Table S2 †) . Overall, Pd-catalyzed coupling through C(sp 3 )-H activation was shown to be highly robust and efficient in the preparation of cyclic peptides with novel Cb-Ar crosslinks (Scheme S3 †). The fact that tetrapeptides with para-or ortho-I-Phe could not be cyclized prompted us to investigate the principle underlining these observations. We reasoned that the cyclic tetrapeptides resulting from macrocyclization were highly constrained, and therefore, conformational organization of linear precursor peptides must allow two reactive ends to coordinate with the catalyst in close spatial proximity before ring closure. We then synthesized peptide 1m with a Pro residue at position 3, which introduced a conformational turn into the linear precursor tetrapeptide. To our delight, the cyclization of peptide 1m proceeded extremely well with almost full conversion as monitored by HPLC with an isolation yield of 87%, indicating the impact of peptide conformation on cyclization efficiency. Pro- Phth-Ala-Leu-Gly-m-I-Phe-OMe 2b 55 1c
Phth-Ala-Val-Gly-m-I-Phe-OMe 2c 58 1d
Phth-Ala-Ile-Gly-m-I-Phe-OMe 2d 53 1e
Phth-Ala-Phe-Gly-m-I-Phe-OMe 2e 58 1f
Phth-Ala-Gly-Gly-Ala-m-I-Phe-OMe 2f 62 1g
Phth-Aib-Gly-Gly-m-I-Phe-OMe 2g 52 1h
Phth-Phe-Gly-Gly-m-I-Phe-OMe 2h 19 1i
Phth-Ala-Ser(tBu)-Gly-m-I-Phe-OMe 2i 60 1j
Phth-Ala-Lys(Boc)-Gly-m-I-Phe-OMe 2j 65 1k
Phth-Ala-Asp(OMe)-Gly-m-I-Phe-OMe 2k 65 1l
Phth-Ala-Gly-Gly-m-I-Phe-Gly-Resin 2l 21 1m
Phth-Ala-Gly-Pro-m-I-Phe-OMe 2m 87 1n
Phth-Ala-Gly-Pro-Ala-m-I-Phe-OMe 2n 63 1o
Phth-Ala-Gly-Pro-Ala-p-I-Phe-OMe 2o 50 1p
Phth-Ala-Arg(Pbf)-Gly-Asp(OMe)-m-I-Phe-OMe 2p 23
containing pentapeptide 1n also cyclized efficiently. Interestingly, pentapeptide 1o (Table 1) , which contains a Pro residue and a para-I-Phe, cyclized smoothly with a yield of 50% (Scheme S3 †). This result suggested that the failure of tetrapeptides containing of para-or ortho-I-Phe to cyclize was most likely due to conformational bias, instead of inherent reactivity. The insertion of a Pro residue, a conformational turn-inducing element, might relieve the constraint of the cyclic pentapeptide and facilitate Cb-Ar crosslinking.
Biological evaluation of cyclic peptides
To evaluate the potential of the Cb-Ar cyclized peptides for biological applications, we synthesized a novel cyclic RGD peptide 2p following this procedure (Fig. 3) . We rst examined the proteolytic stability of 2p in comparison with its linear counterpart 1p. Peptides 1p and 2p were incubated with endoprotease AspN, which hydrolyzes peptide bonds on the Nterminal side of Asp residue. Results showed that in the presence of AspN, cyclic peptide 2p remained intact for up to 5 h, whereas its linear counterpart 1p degraded quickly with a halflife of 50 min and was fully consumed in 5 h, as determined by HPLC and MS analysis (Fig. 3) . Similar results were observed when peptides 1j 0 and 2j 0 , which were resulted from deprotected peptides 1j and 2j, were incubated with protease trypsin (Fig. 3) , where peptide 1j 0 had a half-life of only 21 min, and up to 95% cyclic peptide 2j 0 remained intact aer 5 h. These results demonstrate that the Cb-Ar linkage in cyclic peptides signi-cantly improved their stability against proteolytic degradation. Next, we examined the binding of cyclic RGD peptide 2p to U87MG cells, which is a glioblastoma cell line overexpressing the avb3 integrin. The RGD sequence is well known for its selective binding to integrins when incorporated in proper cyclic structures. 39 Fluorescein isothiocyanate (FITC) was then conjugated to the N-terminal amine of 2p to yield uorescent-labelled 2p-FITC. Linear peptide 1p was also labelled with FITC as a direct comparison. As a positive control, we employed a commercially available cyclo-(RGDfK) and conjugated a FITC moiety onto the Lys amine. U87MG cells were then incubated with 1p-FITC, 2p-FITC and cyclo-(RGDfK)-FITC for 90 min and analyzed by confocal microscopy. As expected, cyclo-(RGDfK)-FITC elicited strong uorescence staining of cells, whereas the linear peptide conjugate 1p-FITC yielded low uorescence, suggesting its weak binding to integrins (Fig. 4a and b) . Interestingly, cyclic peptide 2p-FITC caused slightly stronger uo-rescence staining than cyclo-(RGDfK)-FITC, indicating that the cyclic structure introduced by a Cb-Ar linkage in 2p signi-cantly enhanced the integrin binding of the RGD sequence. These results nicely demonstrated the applicability of cyclic peptides with Cb-Ar linkages in biological systems.
Application in natural product synthesis
Finally, we applied this macrocyclization methodology to natural product synthesis. Several peptide natural products containing Cb-Ar linkages have been identied in recent years. For example, streptide is a recently characterized ribosomally synthesized and posttranslationally modied peptide (RiPP) featuring a C-C crosslink between Trp C5 and Lys Cb (Fig. 5a ).
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Celogentin C, a nonribosomal peptide possessing inhibitory activity against tubulin polymerization, contains a direct linkage of Trp C6 to Leu Cb (Fig. 5a) . 41 Towards the total synthesis of celogentin C, Chen and co-workers employed a Pdcatalyzed strategy to construct the Leu1-Trp C-C bond with the assistance of a quinolone directing group. 36, 42 We postulated that our C-H activation macrocyclization strategy would allow the construction of the celogentin C-ring A from a precursor peptide containing 6-I-Trp and avoid the introduction and removal of directing groups (Fig. 5c) . Accordingly, we synthesized a 6-I-Trp containing precursor peptide 1q (Table 1) and subjected it to macrocyclization. 36 Gratifyingly, peptide 1q cyclized smoothly under coupling conditions, affording the desired cyclic peptide 2o in 32% isolated yield. Structural characterization of 2q was conducted by HPLC, HRMS and NMR analysis. Product 2q appeared as a sharp single peak in analytical HPLC, suggesting a single diastereoisomer (Fig. S3 †) . A correlation between Trp C6 and Leu1 bH was observed in HMBC analysis, indicating the direct Leu1 bC-to-Trp C6 linkage in 2q (Fig. S4 †) . The large vicinal coupling (Jab(Leu1) ¼ 12.0 Hz) and the absence of correlation in NOESY analysis between Ha and Hb of b s -Leu1 strongly suggested an antiperiplanar arrangement of these two protons (Fig. S5 †) , meaning that the conguration of Leu1 Cb in 2q is R and thus identical to the Leu2 Cb of the natural product celogentin C. 41 Further derivatizations of 2q yielded compound 2r, the ring A of celogentin C. The 1 H NMR and 13 C NMR spectra of compound 2r is in very good agreement with the same compound reported by Chen's group, which further supports the correct conguration of Leu1 Cb. 36 This remarkable stereoselective 6-indolation of Leu Cb in cyclic peptide 2q suggested that analogous to the palladium complex formed with directing groups, 36 the amide bond N,Nbiscoordinated complex generated during peptide cyclization promoted the formation of the trans-palladacycle intermediate (Fig. S6 †) . 37 In addition, the successful formation of the bC-Trp C6 linkage further expands the scope of this methodology to iodine-substituted indoles and b-branched amino acids.
Conclusions
In this work, we have developed a robust procedure to generate cyclic peptides with Cb-Ar linkages through Pd-catalyzed C(sp 3 )-H activation, which proceeds smoothly in both solution-phase and solid-phase peptide synthesis. This method allows a diverse set of amino acids to serve as peptide stapling sites and therefore could greatly expand the structural diversity of cyclic peptide libraries. This method has a broad scope of peptide substrates, including tetra-and pentapeptides, and it has been demonstrated as a powerful tool in natural product synthesis by introducing a Cb-Ar bond with high regio-and stereoselectivity. In addition, we demonstrated that a RGD cyclic peptide generated through this method has improved proteolytic stability and higher binding affinity to integrin than a commercially available cyclo-(RGDfK). The generation of natural products and peptidomimics of biological importance through this strategy is in progress in our laboratory.
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